Please join us in congratulating the newly elected and re-elected Council Officers who joined the AATB Board of Governors at the conclusion of the AATB Annual Business Meeting Wednesday, September 21, 2022.

The FDA released an official response to AATB's Citizen Petition.

In May 2022, clusters of monkeypox cases appeared in several countries where it is not endemic.

On Thursday, August 4, The Lancet published Nationwide Tuberculosis Outbreak in the United States Linked to a Bone Graft Product: An Outbreak Report.

Since May 2022, monkeypox cases, which have historically been rare in the United States, have been identified in at least 47 states and territories (CDC).

AATB is pleased to announce the incoming 2022-2024 Council Officers.

The AATB biennial election for 2022-2024 Council Officers opens June 1.

AATB is seeking nominations for the eight AATB councils in the following leadership positions: Chairperson, Vice-Chairperson, and Secretary.

AATB's legal counsel sent an email to the FDA Office of Chief Counsel requesting a meeting to discuss potential litigation against the FDA regarding its reclassification of human acellular dermal matrix (hADM) allografts for post-mastectomy breast reconstruction.